Using Biomarkers for Cognitive Enhancement and Evaluation in Mobile Applications

Clinicians are increasingly using biomarkers to diagnose and monitor cognitive conditions such as mild cognitive impairment, Alzheimer's disease, and dementia. Biomarkers are classified into two main categories based on their clinical goal: disease-associated biomarkers and drug-related biomarkers. In the case of disease-associated biomarkers, neuroimaging biomarkers are used to predict and validate Alzheimer's disease at any of its stages including mild cognitive impairment. The use of mobile and wearable devices to collect data about a person's daily activities and behaviors has led to the emergence of a new type of biomarker known as digital biomarkers. This type of data provides a digital reflection of a person's function in the context of everyday life and can be used to monitor and track changes in an individual's health and behaviors over time. The use of biomarkers in mobile applications for cognitive enhancement and evaluation can provide valuable insights into an individual's cognitive health and can help to optimize treatment and prevention strategies.